This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Related articles in Am J Pathol Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Furling, D. Articles by Morris, G. E. Search for Related Content PubMed PubMed Citation Articles by Furling, D. Articles by Morris, G. E.

(American Journal of Pathology. 2003;162:1001-1009.)
© 2003 American Society for Investigative Pathology

Changes in Myotonic Dystrophy Protein Kinase Levels and Muscle Development in Congenital Myotonic Dystrophy

Denis Furling^*, Le Thanh Lam, Onnik Agbulut^*, Gillian S. Butler-Browne^* and Glenn E. Morris

From the Centre National de la Recherche Scientifique Unité Mixte de Recherche (CNRS UMR) 7000,^* Faculté de Médecine Pitié-Salpêtrière, Paris, France; and the Biochemistry Group, North East Wales Institute, Wrexham, United Kingdom

Myotonic dystrophy (DM1) is caused by the expansion of a CTG repeat in the noncoding region of a protein kinase, DMPK, expressed in skeletal and cardiac muscles. The aim of the present study was to determine the effects of very large CTG expansions on DMPK expression and skeletal muscle development. In fetuses suffering from the severe congenital form of DM1 with large CTG expansions (1800 to 3700 repeats), the skeletal muscle level of DMPK was reduced to 57% of control levels and a similar reduction was observed in cultured DM1 muscle cells relative to control cultures. These results are consistent with greatly reduced DMPK expression from the mutant allele and normal expression from the unaffected allele in this autosomal dominant disorder. In normal fetuses, DMPK protein levels increased dramatically between 9 and 16 weeks and remained high throughout the remaining gestation period. DM1 fetuses showed impaired skeletal muscle development, characterized by a persistence of embryonic and fetal myosin heavy chains and almost total absence of slow myosin heavy chains at the end of gestation. DMPK expression, however, was similar in both fast and slow fibers from normal adult muscle. The reduced DMPK and the delayed slow fiber maturation in congenital DM1 may be two separate consequences of nuclear retention of DMPK RNA transcripts with expanded CUG repeats.

Related articles in Am J Pathol:

This Month in AJP

Am J Pathol 2003 162: 703-704. [Full Text]  

This article has been cited by other articles:

				R. J. Osborne and C. A. Thornton RNA-dominant diseases Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R162 - R169. [Abstract] [Full Text] [PDF]

				M.-A. Langlois, C. Boniface, G. Wang, J. Alluin, P. M. Salvaterra, J. Puymirat, J. J. Rossi, and N. S. Lee Cytoplasmic and Nuclear Retained DMPK mRNAs Are Targets for RNA Interference in Myotonic Dystrophy Cells J. Biol. Chem., April 29, 2005; 280(17): 16949 - 16954. [Abstract] [Full Text] [PDF]

				D. F. O'Cochlain, C. Perez-Terzic, S. Reyes, G. C. Kane, A. Behfar, D. M. Hodgson, J. A. Strommen, X.-K. Liu, W. van den Broek, D. G. Wansink, et al. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy Hum. Mol. Genet., October 1, 2004; 13(20): 2505 - 2518. [Abstract] [Full Text] [PDF]

				C. J. Storbeck, S. Drmanic, K. Daniel, J. D. Waring, F. R. Jirik, D. J. Parry, N. Ahmed, L. A. Sabourin, J.-E Ikeda, and R. G. Korneluk Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR Hum. Mol. Genet., March 15, 2004; 13(6): 589 - 600. [Abstract] [Full Text] [PDF]